| Sandoz Pharmaceuticals AG - Rivastigmin Patch Sandoz eco 9,5 mg/24 h (18 mg), transdermale Pflaster |
| 70340 | | 02 | | Rivastigmin Patch Sandoz eco 9,5 mg/24 h (18 mg) | | transdermale Pflaster | | N06DA03 | | Rivastigmin | | 16.04.2026 | | |
|
| Composition |
| rivastigminum 18 mg, acidi acrylici et acrylates polymerisatum, ammonio methacrylatis copolymerum B, acrylates polymerisatum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte (Schwarz): ad praeparationem pro 10.5 cm² cum liberatione 9.5 mg/24h. |
| Packungsbestandteile |
| Timbre transdermique | | | | Principe actif | Concentr. |
|---|
| Rivastigmine | 18 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Acrylici | | | | Acrylates Polymerisatum | | | | Ammonio Methacrylatis Copolymerum B | | | | Cum Liberatione | 9.5mg / 24h | | | Drucktinte (Schwarz): ad Praeparationem | 10.5 cm | | | Poly(Ethylenis Terephthalas) | | Trägermaterial |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 | | | B | | Oui | | 003 | 60 | | | B | | Oui |
|
